en/health – 25. oldal

• Weight-Loss Trends, Celebrity Headlines, and the Real Health Questions to Ask
  2026-01-31

  From “sardine fasting” to pricey weight-loss products and detox claims, today’s headlines show how easy it is to confuse buzz with evidence. Here’s how to evaluate weight-loss stories and protect your health (and wallet).

• Weight-Loss in 2026: What’s Driving the Boom, What Can Go Wrong, and How to Choose a Safer Path
  2026-01-31

  Weight-loss drugs, new oral pills, and app-based coaching are reshaping how people manage obesity—but they also bring real medical trade-offs. Here’s a practical, safety-first guide to understanding the trend, including gallbladder risks and smart questions to ask your clinician.

• Weight-Loss in 2026: Oral GLP-1 Pills, Injection Side Effects, and the Rise of Digital Support
  2026-01-31

  New weight-loss options are arriving fast—from oral GLP-1 medicines to app-based coaching—while doctors continue to warn about side effects like gallbladder problems. Here’s how to compare what’s hype, what’s evidence-based, and what to ask your clinician.

• Weight Loss in 2026: New Medications, What Activity Can (and Can’t) Do, and How to Avoid Online Scams
  2026-01-31

  Weight-loss treatment is changing quickly—especially with rising demand for new drugs and potential insurance coverage shifts. Here’s how to think clearly about medication, activity, and online safety when trying to lose weight.

• Weight Loss in 2026: What’s Driving the Trend—from Daily Activity to New Medications and Coverage Changes
  2026-01-31

  Weight loss headlines are increasingly shaped by behavior science, new GLP-1 treatment options, and shifting insurance coverage. Here’s a practical overview of what’s changing—and what it means for your health decisions.

• Health & Wellness – 2026-01-30
  2026-01-30

  Health & Wellness – 2026-01-30

• Weight Loss in the Spotlight: What Celebrity Stories and New Drugs Reveal About Safer, Sustainable Change
  2026-01-30

  Celebrity weight-loss headlines and major pharma deals are shaping how the public thinks about obesity treatment. Here’s what they can—and can’t—tell us about safe, sustainable weight management, including medication risks like gallbladder problems.

• What a New AstraZeneca–CSPC Deal Signals for the Next Wave of Weight-Loss Medicines
  2026-01-30

  AstraZeneca’s new agreement with China’s CSPC highlights intensifying competition in obesity care and the search for additional options beyond today’s leading injectable drugs. Here’s what the partnership could mean for future treatments, access, and safety expectations.

• Weight Loss in 2026: Separating Medication Risks, New Therapies, and Common Scams
  2026-01-30

  Weight loss headlines span everything from breakthrough drugs to safety warnings and outright fraud. Here’s a practical guide to what’s real, what’s risky, and how to protect your health and your wallet.

• Weight-loss injections in the spotlight: what to know about gallbladder surgery and pancreatitis risk
  2026-01-30

  Reports are linking popular weight-loss injections to more gallbladder removals and a small risk of severe pancreatitis. Here’s what the signals may mean, who might be at higher risk, and how to use these medicines more safely with your clinician.